Endo International PLC (ENDP)

5.63
+0.20(+3.68%)
After Hours
5.63
0.00(0.00%)
- Real-time Data
  • Volume:
    3,918,402
  • Bid/Ask:
    5.55/5.63
  • Day's Range:
    5.50 - 5.74

ENDP Overview

Prev. Close
5.43
Day's Range
5.5 - 5.74
Revenue
2.9B
Open
5.55
52 wk Range
2.71 - 10.88
EPS
0.5
Volume
3,918,402
Market Cap
1.31B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
3,406,308
P/E Ratio
11.23
Beta
1.46
1-Year Change
35.34%
Shares Outstanding
233,305,326
Next Earnings Date
Aug 09, 2021
What is your sentiment on Endo International PLC?
or
Market is currently closed. Voting is open during market hours.

Endo International PLC News

Endo International PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuySellSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell

Endo International PLC Company Profile

Endo International PLC Company Profile

Employees
3397

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.

Read More
  • This company is a joke! Every rise is dumped! What a scam!!!
    0
    • what a scam!!!
      2
      • greetings everyone! any ideas on why such a fall today? were there any particular reasons for that or just a global market correction?
        0
        • Jasbir Dhillon looks like it's because of opioid crisis lawsuits...
          0
        • kek pek most of them have been settled, and this is just pushing it. Pure price manipulation happening now.
          0
        • kek pek and large sell-offs last week to follow red market
          0
      • Airforce Exclusive Patent License! https://www.federalregister.gov/documents/2021/01/12/2021-00403/notice-of-intent-to-grant-an-exclusive-patent-license
        0
        • selling soon!!
          0
          • so clearly not a man of your word. you said you are out nearly 5 days ago but still haven't sold your stock. Are you also a Trump supporter?
            3
        • I'm out! this is really without chance to recover! good news but shares fall! sell this scrap!! before it plunges even deeper! save something from your investment NOW!!
          0
          • what a mess!
            2
            • Francesco Pirritano in a few days she took back everything she had earned but ... I'm a bit worried
              0
            • Paola Garifi Let's wait tomorrow first and let's see. The cases and fear are raising so the market is very volatile in this period. Be patient and time will talk
              0
            • Francesco Pirritano the doubt arises from the fact that my average is around 4.40 ... maybe I still have time to sell and buy back at a lower price
              0
          • ENDP. Committed to this position longer term and through 2021. :-)
            1
            • ENDP. Another good week for shares. Looking for the stock to return to $7 near term. This one is way under the radar and I like that! Have a nice weekend!
              1
              • Many here also own NVAX another stock worth investing right now. I own long term positions in both. :-)
                0
              • So if you don’t own NVAX but own ENDP, take a look at NVAX. Lots of good stuff ahead for that company. :-)
                0
            • Great going! "Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as Ready-to-Use Vials" - https://medicircle.in/nevakar-announces-fda-approval-for-ephedrine-sulfate-injection-as-readytouse-vials "Under an exclusive licensing agreement with Endo International’s (NASDAQ: ENDP) subsidiary, Endo Ventures Limited, Par Pharmaceuticals’ Sterile Products division will launch and distribute the product."
              1
              • Justin Hall are you alive? Hopefully you can shear some thoughts about ENDP and NVAX
                0
                • Hahaha! Alive and well. Just riding out the storm and keeping busy. :-)
                  0
                • Nice to hear from you :) WHAT is your “cristal mind” telling about ENDO?
                  0
                • I like it long term, Iva. My target is $15-$20 in 2021.
                  0
              • It had crossed 6.12 in the pre-market, should reach 7 by tomorrow.
                0
                • Looks good going forward. :-)
                  0
              • ENDP. On Fire. Heading back to $7+. Last: $5.65. So impressive today. :-)
                1
                • last friday I sold my shares and I bought nvax. 😤
                  0
                • Own both!
                  0
                • Looks good.
                  0
              • Very good news!!! "BioSpecifics to be Acquired by Endo Pharmaceuticals" --> https://finance.yahoo.com/news/biospecifics-acquired-endo-pharmaceuticals-113000651.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAACjDa7Wtcyje6TtrKBI7vCFgamKghwGLMc56xCFzNAWug_wq9v2hCb1ix4_eUtbbCWqhgVJp8hwlyXwGCkcgRxratGv2PanDBgqgNOvq5XeEBGJmnL9d_HZK1wAMkXcjMBUGnoux786yMRPuwd1MfFyGheLD8rxjfWfis8J0QAiL
                0
                • ENDP is on fire!
                  0
                • Justin Hallgood.. i jump in the boat at 5.01 finally
                  0
                • Been in since the $3.75 range. Wish I had put a little more in on this one. Lookin good!
                  0
              • ENDP. Need to see shares break through $5.16 today, 10/16/20. Last: $5.13.
                0
                • Did not happen. Hmmm.
                  0
                • ENDP now trading at $5.25 in early trading on 10/19/20. Bam! :-)
                  0
              • ENDP. By month end (10/31), $7 is highly likely if things continue like they are. :-)
                1
                • $7.11 will make a new 52-week high for shares. It’s coming. :-)
                  1
                • Awww. Haters following me. Loser.
                  0
                • Hey Hater Boy, scroll down to June 20, 2020. That’s when I started commenting on ENDP. Here’s how you do it: 1. Find YOUR own ENDP and 2. Help OTHERS to find it as well. But most importantly, 3. GET IT RIGHT ... CONSISTENTLY. You waste time following me around and negating my posts. You cannot beat me that way. ;-)
                  0
              • Agree!
                0
                • ENDP. Could potentially return to $7 before earnings on 11/5. Hmmm.
                  0
                  • justin I learned this stock from you and won it. thanks
                    0
                    • Good work Beytullah! I like it longer term and plan to hold it until it revisits $20. The way I do it is just add more shares along the way. I wish you the best my friend. :-)
                      0
                    • Thanks I will follow your advice👍
                      0
                    • GLAD TO SEE ANN! :-)
                      0
                  • Hi Justin Have also joined the ENDP team Have a good day!
                    0
                    • A good week for them. :-)
                      0
                    • Just stick it out longer term and you’ll be glad you did. :-)
                      0
                  • ENDP. 10/9/20 1:23 AM ET. Shares closed 10/8 trading at $4.85. Looking good heading into 2021.
                    0
                    • Thank you to whoever is now following me around to get my comments removed. You will fuel me to work harder. Loser.
                      0
                  • ENDP. 10/8/20 AH. Shares closed at $4.85 today. Looks good as we enter Q4 2020. :-) ENDP should be viewed as a long term investment.
                    0
                    • ENDP. 10/6/20 1:27 PM ET, shares are now trading at $4.38. Nice 17.58% gain for the day. :-) My 2021 target for ENDP is $15-$20. Stick with it.
                      0
                      • Endo Begins Shipment of Generic Kuvan® Tablets and Powder for Oral Solution (sapropterin dihydrochloride) https://www.prnewswire.com/news-releases/endo-begins-shipment-of-generic-kuvan-tablets-and-powder-for-oral-solution-sapropterin-dihydrochloride-301144510.html
                        0
                        • ENDP. 10/5/20 9:30 AM. Shares are nearing $3.50 this morning and heading to $4+. Last: $3.49.
                          0
                          • Justin thank you so much for your comments! They are very useful also in NVAX.
                            0
                          • Thank you Francesco. Appreciate you, my friend. :-) Good luck with both!
                            0
                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.